share_log

Quince Therapeutics Sees FY23 Annual Capital, Operating Expenditures ~$11M

Benzinga Real-time News ·  Jan 30, 2023 16:13
Quince Therapeutics Sees FY23 Annual Capital, Operating Expenditures ~$11M
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment